Page last updated: 2024-08-24

ranolazine and Cardiometabolic Syndrome

ranolazine has been researched along with Cardiometabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braunwald, E; Chaitman, BR; Karwatowska-Prokopczuk, E; McCabe, CH; McGuire, DK; Morrow, DA; Murphy, SA; Scirica, BM	1

Trials

1 trial(s) available for ranolazine and Cardiometabolic Syndrome

Article	Year
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation, 2009, Apr-21, Volume: 119, Issue:15 Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Cardiovascular Agents; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Recurrence	2009

Article

Year

Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.

Circulation, 2009, Apr-21, Volume: 119, Issue:15

Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Cardiovascular Agents; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Recurrence

2009